T&L Co., Ltd. (340570.KQ)

Full history for every metric is available with a Kvantra account

Stock profile
T&L Co., Ltd. logo

T&L Co., Ltd. (340570.KQ)

Country: South KoreaSector: HealthcareIndustry: Medical - DevicesExchange: KOE
P/E TTM
24.7
History
P/E NTM
8.2
Market cap
464.99B
Currency KRW
KvantraRanki82
Value76
Quality93
Momentum76
Current price
29,650.00+1.19%
Benchmarks

No price history available.

Key financial summary

Financials in KRW
202020212022202320242025TTM2026E
Total revenueKRW bn417282115175164175187
Operating profitKRW bn4659
Net profitKRW bn1020212746385157
EPS reportedKRW2,3633,162
Operating cashflow per shareKRW2,3392,883
Capex per shareKRW1,122950.3
FCF per shareKRW1,2161,933
Free cash flowKRW bn2031
Net debtKRW bn-91-36
Book value equityKRW bn201224
Book value per shareKRW12,48213,985
Number of sharesm16.1216.03
DPS (TTM paid)KRW750.0750.0

Financial summary

Financials in KRW
202020212022202320242025TTM2026E
Value
P/E TTMx10.3824.68
P/B LTMx1.961.76
P/S LTMx2.412.26
P/FCF LTMx20.1612.76
EV/EBITDA LTMx6.134.70
EV/Sales LTMx1.962.51
Earnings Yield LTM%+9.63%+4.05%
FCF Yield%+4.96%+7.84%
Quality
ROE%+18.93%+24.47%
ROIC%+18.05%+20.54%
Operating margin%+28.24%+33.90%
Gross margin%+44.10%+47.58%
FCF/Sales%+11.94%+17.69%
Growth and momentum
EPS Growth YoY%-17.81%+10.01%
Sales Growth YoY%-6.14%+0.15%
Net Income Growth YoY%-17.96%+9.42%
FCF Growth%-34.99%+2.73%
Operating Profit Growth%-18.62%+4.26%
Dividend and capital structure
Dividend Yield%+1.53%+2.53%
Dividend Growth%+100.00%+100.00%
Payout Ratio%+15.90%+15.66%
FCF/Debtx61.72123.84
Net Debt/EBITDAx-1.40-0.53
EBIT/Net interestx3,451.546,406.05
Net debt/market cap%+0.04%+0.03%
Net debt/Equityx-0.45-0.16
Gross debt/equityx0.000.00

Ratings

Strong Buy
Buy
Hold
Sell
Strong Sell
Number of covering analysts

Based on consensus from external analysts. Not Kvantra's opinion.

Company overview

Operating out of South Korea, T&L Co., Ltd. specializes in developing and marketing a variety of medical and polymer-based materials. The company's diverse product portfolio features chemical compounds like water-borne resins, hardeners, functional additives, and urethane foam. It also provides a wide array of wound care items, including hydrocolloid, foam, hydrogel, silicone, and alginate dressings. Additionally, T&L manufactures orthopedic goods such as casts and splints. The firm was established in 1998 and maintains its headquarters in Yongin-si, South Korea.

Websitetnl.co.kr
SectorHealthcare
IndustryMedical - Devices
CountrySouth Korea
Trades inKRW

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

T&L Co., Ltd. (340570.KQ)

340570.KQ · KOE · Healthcare
29,650.00+1.19%
Sign up to track this stock

No price history available.

KvantraRank82
Market cap464.99B
P/E NTM8.2
P/E TTM24.7
KvantraRank?82 / 100
Value
76
Quality
93
Momentum
76
Financialsin KRW
20242025TTM2026E
Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell

Based on consensus from external analysts. Not Kvantra's opinion.

About

Operating out of South Korea, T&L Co., Ltd. specializes in developing and marketing a variety of medical and polymer-based materials. The company's diverse product portfolio features chemical compounds like water-borne resins, hardeners, functional additives, and urethane foam. It also provides a wide array of wound care items, including hydrocolloid, foam, hydrogel, silicone, and alginate dressings. Additionally, T&L manufactures orthopedic goods such as casts and splints. The firm was established in 1998 and maintains its headquarters in Yongin-si, South Korea.

Websitetnl.co.kr
SectorHealthcare
IndustryMedical - Devices
CountrySouth Korea
Trades inKRW

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free